Diabetes-management firm Insulet (NASDAQ: PODD) of Bedford, MA, filed with the SEC for a secondary public offering of some 4.8 million shares. Insulet went public in May with an offering of 7.7 million shares at $15 per share. The stock closed Friday at $23.77.
Author: Rebecca Zacks
Rebecca is Xconomy's co-founder. She was previously the managing editor of Physician's First Watch, a daily e-newsletter from the publishers of New England Journal of Medicine. Before helping launch First Watch, she spent a decade covering innovation for Technology Review, Scientific American, and Discover Magazine's TV show. In 2005-2006 she was a Knight Science Journalism Fellow at MIT. Rebecca holds a bachelor's degree in biology from Brown University and a master's in science journalism from Boston University.
View all posts by Rebecca Zacks
